Fig. 6

PKO mice show enhanced inflammatory cell extravasation after ICH. a Immunohistochemistry of Ly6G in control and PKO brains from sham group and at D2, D5, and D14 after ICH. b Quantification of Ly6G⁺ neutrophils in control and PKO mice. *p < 0.05, compared to controls at the same time points (ANOVA followed by Newman-Keuls test), n = 3–4. c Immunohistochemistry of CD3 in control and PKO brains from sham group and at D2, D5, and D14 after ICH. d Quantification of CD3⁺ T cells in control and PKO mice. **p < 0.01 and ***p < 0.001, compared to controls at the same time points (ANOVA followed by Newman-Keuls test), n = 3–4. e Immunohistochemistry of CD11b in control and PKO brains from sham group and at D2, D5, and D14 after ICH. f Quantification of CD11b⁺ microglia/macrophages in control and PKO mice. *p < 0.05, **p < 0.01, and ***p < 0.001, compared to controls at the same time points (ANOVA followed by Newman-Keuls test), n = 3–4. Data are shown as mean ± SD